STOCK TITAN

[8-K] Flora Growth Corp. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Flora Growth Corp. filed an 8-K reporting a material event and included standard forward-looking statements and risk disclosures. The filing lists potential risks that could materially affect results, including possible impairment charges if the market price of 0G declines below book value, share price volatility from future issuances, uncertainty from changing interest rates, the company’s ability to achieve and maintain profitability, regulatory and compliance complexities, potential changes in accounting for its 0G holdings, general economic conditions, growth management challenges, and access to capital. The statements are dated and the company disclaims any obligation to update forward-looking statements except as required by law.

Flora Growth Corp. ha depositato un 8-K riportando un evento di rilievo e incluso dichiarazioni prospettiche standard e avvertenze sui rischi. Il deposito elenca rischi potenziali che potrebbero influire materialmente sui risultati, tra cui possibili oneri di impairment se il prezzo di mercato di 0G scende al di sotto del valore contabile, volatilità del prezzo delle azioni dovuta a future emissioni, incertezza derivante da tassi di interesse in cambiamento, la capacità dell'azienda di raggiungere e mantenere la redditività, complessità normative e di conformità, potenziali cambiamenti nel metodo contabile per le sue partecipazioni in 0G, condizioni economiche generali, sfide di gestione della crescita e accesso al capitale. Le dichiarazioni sono datate e l'azienda si disinteressa da qualsiasi obbligo di aggiornare le dichiarazioni previsionali salvo quanto richiesto dalla legge.

Flora Growth Corp. presentó un 8-K reportando un evento material e incluyó declaraciones prospectivas estándar y divulgaciones de riesgos. El archivo enumera riesgos potenciales que podrían afectar materialmente los resultados, incluyendo posibles cargos por impairment si el precio de mercado de 0G cae por debajo del valor en libros, volatilidad del precio de las acciones por futuras emisiones, incertidumbre por cambios en las tasas de interés, la capacidad de la empresa para alcanzar y mantener la rentabilidad, complejidades regulatorias y de cumplimiento, posibles cambios en la contabilidad de sus participaciones en 0G, condiciones económicas generales, desafíos en la gestión del crecimiento y acceso a capital. Las declaraciones están fechadas y la empresa niega cualquier obligación de actualizar las declaraciones prospectivas salvo cuando la ley lo exija.

Flora Growth Corp.가 중대한 사건을 보고하고 표준적인 향후 전망 진술 및 리스크 공시를 포함한 <8-K>를 제출했습니다. 공시는 결과에 실질적인 영향을 미칠 수 있는 잠재적 위험을 나열하고 있으며, 0G의 시가가 장부가치를 하회할 경우의 <손실인식 비용 가능성, 향후 발행으로 인한 <주가 변동성>, 변동하는 <금리>로 인한 불확실성, 회사가 <수익성을 달성하고 유지하는> 능력, 규제 및 컴플라이언스의 복잡성, 0G 보유자산에 대한 회계 변경 가능성, 일반 경제 여건, 성장 관리의 도전, 자본 접근성 등을 포함합니다. 진술은 날짜가 기재되어 있으며 법이 요구하는 경우를 제외하고는 향후 진술을 업데이트할 의무를 부인합니다.

Flora Growth Corp. a déposé un 8-K signalant un événement important et a inclus des déclarations prospectives standard et des informations sur les risques. Le dépôt répertorie des risques potentiels pouvant affecter de manière significative les résultats, notamment d'éventuelles charges d'impairement si le cours du marché de 0G tombe en dessous de la valeur comptable, la volatilité du cours des actions due à de futures émissions, l'incertitude liée à la variation des taux d'intérêt, la capacité de l'entreprise à atteindre et maintenir la rentabilité, les complexités réglementaires et de conformité, les éventuels changements dans la comptabilisation de ses participations dans 0G, les conditions économiques générales, les défis de la gestion de la croissance et l'accès au capital. Les déclarations sont datées et l'entreprise décline toute obligation de mettre à jour les déclarations prospectives sauf si la loi l'exige.

Flora Growth Corp. hat eine 8-K eingereicht, die ein erhebliches Ereignis meldet, und standardmäßige Zukunftsprognosen und Risikohinweise enthält. Die Einreichung listet potenzielle Risiken auf, die die Ergebnisse wesentlich beeinflussen könnten, einschließlich möglicher Impairment-Aufwendungen falls der Marktpreis von 0G unter dem Buchwert liegt, Aktienkursvolatilität infolge zukünftiger Ausgaben, Unsicherheit durch sich ändernde Zinssätze, die Fähigkeit des Unternehmens, Rentabilität zu erzielen und zu halten, regulatorische und Compliance-Komplexitäten, potenzielle Änderungen in der Bilanzierung seiner 0G-Beteiligungen, allgemeine wirtschaftliche Bedingungen, Herausforderungen im Wachstum-Management und Kapitalzugang. Die Aussagen sind datiert und das Unternehmen lehnt jede Verpflichtung ab, zukunftsgerichtete Aussagen außer soweit gesetzlich vorgeschrieben zu aktualisieren.

قامت Flora Growth Corp. بتقديم 8-K يقرّ بحدوث حدث مادي وشمل بيانات تصريحية مستقبلية قياسية وكشوف مخاطر. يسرد الملف مخاطر محتملة قد تؤثر ماديًا على النتائج، بما في ذلك احتمالية رسوم انخفاض القيمة إذا انخفض سعر السوق لـ 0G دون القيمة الدفترية، تقلب سعر السهم نتيجة الإصدار المستقبلي، عدم اليقين من تغير أسعار الفائدة, قدرة الشركة على تحقيق وربما الحفاظ على الربحية, تعقيدات التنظيم والتوافق، احتمال تغير طريقة المحاسبة في ضماناتها لـ 0G، الظروف الاقتصادية العامة، تحديات إدارة النمو، والوصول إلى رأس المال. التصريحات مؤرخة وتنكر الشركة أي التزام بتحديث التصريحات المستقبلية إلا كما يفرضه القانون.

Flora Growth Corp. 已提交一份<8-K>,报告重大事件并包含标准的前瞻性声明和风险披露。该文件列出可能对结果产生重大影响的潜在风险,包括若 0G 的市场价格低于账面价值时的可能 <减值损失>,未来发行引致的 <股价波动>,因为利率变动带来的不确定性,公司实现并维持盈利能力的能力,监管和合规的复杂性,对 0G 持有资产的会计处理变化的潜在可能性,一般经济状况,增长管理挑战,以及资本获取。 声明有日期,公司对除法律要求外的前瞻性声明不承担更新义务。

Positive
  • None.
Negative
  • Impairment risk if market price of 0G falls below carrying value
  • Share-price volatility from future issuances and convertible securities
  • Interest-rate uncertainty that could affect financing costs and valuation
  • Risk to profitability including inability to achieve or maintain profit
  • Regulatory and compliance complexity that could increase costs or restrictions
  • Potential accounting changes for 0G holdings that could alter reported results
  • Access-to-capital risk including debt financing constraints

Insights

TL;DR: The filing is largely forward-looking risk disclosure without new operational metrics.

The 8-K emphasizes a range of investor risks, notably potential impairment charges tied to declines in the market value of the company’s 0G holdings and share dilution/volatility from future issuances. These are standard disclosure items that highlight how market movements and financing decisions could affect reported equity and earnings.

The practical dependencies are observable market prices for 0G, financing activity, and regulatory developments; each could materialize quickly and affect near-term financials. Watch for subsequent filings that quantify any impairment, share issuances, or capital-raising actions within the next reporting period.

TL;DR: The company flags regulatory, accounting, and capital-access risks that could constrain operations or reporting.

The disclosure draws attention to compliance complexity and possible changes in accounting treatment for the company’s 0G holdings, which could change reported results or require restatements if standards or interpretations shift. Access to capital and interest-rate volatility are also called out, highlighting financing risk.

Investors should monitor filings for regulatory outcomes, any announced accounting-policy changes, or debt/equity financings within 90 days to see if these risks are crystallizing into material financial effects.

Flora Growth Corp. ha depositato un 8-K riportando un evento di rilievo e incluso dichiarazioni prospettiche standard e avvertenze sui rischi. Il deposito elenca rischi potenziali che potrebbero influire materialmente sui risultati, tra cui possibili oneri di impairment se il prezzo di mercato di 0G scende al di sotto del valore contabile, volatilità del prezzo delle azioni dovuta a future emissioni, incertezza derivante da tassi di interesse in cambiamento, la capacità dell'azienda di raggiungere e mantenere la redditività, complessità normative e di conformità, potenziali cambiamenti nel metodo contabile per le sue partecipazioni in 0G, condizioni economiche generali, sfide di gestione della crescita e accesso al capitale. Le dichiarazioni sono datate e l'azienda si disinteressa da qualsiasi obbligo di aggiornare le dichiarazioni previsionali salvo quanto richiesto dalla legge.

Flora Growth Corp. presentó un 8-K reportando un evento material e incluyó declaraciones prospectivas estándar y divulgaciones de riesgos. El archivo enumera riesgos potenciales que podrían afectar materialmente los resultados, incluyendo posibles cargos por impairment si el precio de mercado de 0G cae por debajo del valor en libros, volatilidad del precio de las acciones por futuras emisiones, incertidumbre por cambios en las tasas de interés, la capacidad de la empresa para alcanzar y mantener la rentabilidad, complejidades regulatorias y de cumplimiento, posibles cambios en la contabilidad de sus participaciones en 0G, condiciones económicas generales, desafíos en la gestión del crecimiento y acceso a capital. Las declaraciones están fechadas y la empresa niega cualquier obligación de actualizar las declaraciones prospectivas salvo cuando la ley lo exija.

Flora Growth Corp.가 중대한 사건을 보고하고 표준적인 향후 전망 진술 및 리스크 공시를 포함한 <8-K>를 제출했습니다. 공시는 결과에 실질적인 영향을 미칠 수 있는 잠재적 위험을 나열하고 있으며, 0G의 시가가 장부가치를 하회할 경우의 <손실인식 비용 가능성, 향후 발행으로 인한 <주가 변동성>, 변동하는 <금리>로 인한 불확실성, 회사가 <수익성을 달성하고 유지하는> 능력, 규제 및 컴플라이언스의 복잡성, 0G 보유자산에 대한 회계 변경 가능성, 일반 경제 여건, 성장 관리의 도전, 자본 접근성 등을 포함합니다. 진술은 날짜가 기재되어 있으며 법이 요구하는 경우를 제외하고는 향후 진술을 업데이트할 의무를 부인합니다.

Flora Growth Corp. a déposé un 8-K signalant un événement important et a inclus des déclarations prospectives standard et des informations sur les risques. Le dépôt répertorie des risques potentiels pouvant affecter de manière significative les résultats, notamment d'éventuelles charges d'impairement si le cours du marché de 0G tombe en dessous de la valeur comptable, la volatilité du cours des actions due à de futures émissions, l'incertitude liée à la variation des taux d'intérêt, la capacité de l'entreprise à atteindre et maintenir la rentabilité, les complexités réglementaires et de conformité, les éventuels changements dans la comptabilisation de ses participations dans 0G, les conditions économiques générales, les défis de la gestion de la croissance et l'accès au capital. Les déclarations sont datées et l'entreprise décline toute obligation de mettre à jour les déclarations prospectives sauf si la loi l'exige.

Flora Growth Corp. hat eine 8-K eingereicht, die ein erhebliches Ereignis meldet, und standardmäßige Zukunftsprognosen und Risikohinweise enthält. Die Einreichung listet potenzielle Risiken auf, die die Ergebnisse wesentlich beeinflussen könnten, einschließlich möglicher Impairment-Aufwendungen falls der Marktpreis von 0G unter dem Buchwert liegt, Aktienkursvolatilität infolge zukünftiger Ausgaben, Unsicherheit durch sich ändernde Zinssätze, die Fähigkeit des Unternehmens, Rentabilität zu erzielen und zu halten, regulatorische und Compliance-Komplexitäten, potenzielle Änderungen in der Bilanzierung seiner 0G-Beteiligungen, allgemeine wirtschaftliche Bedingungen, Herausforderungen im Wachstum-Management und Kapitalzugang. Die Aussagen sind datiert und das Unternehmen lehnt jede Verpflichtung ab, zukunftsgerichtete Aussagen außer soweit gesetzlich vorgeschrieben zu aktualisieren.


false 2025-10-09 0001790169 00-0000000 Flora Growth Corp. 0001790169 2025-10-09 2025-10-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 9, 2025

FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)

Ontario 001-40397 Not Applicable
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, Florida, United States 33132
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (954) 842-4989

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Shares, no par value   FLGC   NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 7.01 Regulation FD Disclosure

On October 9, 2025, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "Company") published a blog post related to an update on the Company's financials and progress. A copy of that blog post is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein in its entirety by reference. Such blog post, including any information that is incorporated herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the rules and regulations of the SEC thereunder, or the Exchange Act or the rules and regulations of the SEC thereunder, except as shall be expressly set forth by specific reference in such filing or document.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Blog post of Flora Growth Corp. dated October 9, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Cautionary Statement Regarding Forward-Looking Statements

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," strategy," "future," "likely," "may,", "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of  $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G")  and any associated impairment charges that the Company may incur as a result of a decrease in the market price of 0G below the value at which the Company's 0G are carried on its balance sheet; (ii) volatility in our share price, including due to future issuances of common shares and securities convertible into common shares; (iii) the effect of and uncertainties related the ongoing volatility in interest rates; (iv) our ability to achieve and maintain profitability in the future; (v) the impact on our business of the regulatory environment and complexities with compliance related to such environment including changes in securities laws or other laws or regulations; (vi) changes in the accounting treatment relating to the Company's 0G holdings; (vii) our ability to respond to general economic conditions; (viii) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (ix) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth and (x) other risks and uncertainties more fully in the section captioned "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other reports and/or registration statements we file with the SEC. As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this report. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  FLORA GROWTH CORP.
     
Date: October 10, 2025 By: /s/ Dany Vaiman
  Name: Dany Vaiman
  Title: Chief Financial Officer


FAQ

What did Flora Growth (FLGC) disclose in the 8-K dated 2025-10-09?

Key disclosure: the company filed a material event notice containing forward-looking statements and a list of risks including potential impairment of 0G holdings, share volatility, interest-rate effects, regulatory and accounting risks, and access-to-capital concerns.

Does the filing report any realized impairment or quantified losses for FLGC?

No quantified impairment or specific loss figures are reported in the provided text.

What specific assets are mentioned as subject to impairment risk?

The filing refers to the company’s holdings of 0G and potential impairment charges if market price declines below carrying value.

Does the company commit to updating its forward-looking statements?

The company states it undertakes no duty to update forward-looking statements except as required by applicable law.

Which factors could cause the company’s actual results to differ materially?

Listed factors include market price declines, share issuances, interest-rate volatility, regulatory changes, accounting treatment changes, economic conditions, growth-management challenges, and access to capital.
Flora Growth Corp

NASDAQ:FLGC

FLGC Rankings

FLGC Latest News

FLGC Latest SEC Filings

FLGC Stock Data

13.55M
639.80k
12.54%
4.08%
1.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
FORT LAUDERDALE